Inactive Instrument

Other languages Forma Therapeutics Holdings, Inc.

Equities

FMTX

US34633R1041

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

Sector Update: Health Care Stocks Ending with Modest Declines	15/22/15
Sector Update: Health Care Stocks Sliding with Broader Friday Markets	15/22/15
Novo Nordisk Completes Acquisition of Forma Therapeutics; Forma Shares to be Delisted	14/22/14
Novo Nordisk : finalise l'acquisition de Forma Therapeutics	14/22/14
Novo Nordisk Completes Acquisition of Forma Therapeutics	14/22/14
Forma Therapeutics Holdings, Inc. Announces Board Changes	14/22/14
Novo Nordisk A/S (CPSE:NOVO B) completed the acquisition of Forma Therapeutics Holdings, Inc. (NasdaqGM : FMTX) from RA Capital Management, L.P. and others.	13/22/13
LATE BRIEFING - Unternehmen und Märkte -2-	01/22/01
Novo Nordisk to Acquire Forma Therapeutics in $1.1 Billion Deal	01/22/01
Novo Nordisk To Acquire US-based Forma Therapeutics For $1 Billion	01/22/01
Aktien New York Ausblick: Vier Tage Talfahrt und weiterhin kein Lichtblick	01/22/01
Novo Nordisk : rachat de Forma Therapeutics pour 1,1 Md$	01/22/01
Novo Nordisk kauft Forma Therapeutics für 1,1 Mrd US-Dollar	01/22/01
Novo Nordisk to acquire Forma Therapeutics in $1.1. billion deal	01/22/01
Forma Therapeutics Holdings Q2 Net Loss Widens	05/22/05
Forma Therapeutics Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	05/22/05
Rigel Pharmaceuticals, Inc. and Forma Therapeutics Holdings, Inc. Announces Licensing Agreement for Olutasidenib, a Novel Mutant IDH1 Inhibitor for the Potential Treatment of Relapsed or Refractory Acute Myeloid Leukemia	03/22/03
Forma Therapeutics Holdings, Inc. Announces Executive Changes	26/22/26
Forma Therapeutics Announces Appointment of New Executive Team Members	30/22/30
Forma Therapeutics Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	06/22/06

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Forma Therapeutics Holdings, Inc.

Equities

FMTX

US34633R1041

Other languages

Filters